![](https://investorshub.advfn.com/uicon/60294.png?cb=1611719355)
Thursday, March 08, 2018 11:53:13 AM
sweet deals between Elite & Mikah? How about Trimipramine? Nothing but garbage to line his pockets.
Complete and total NONSENSE. Total misinformation at it's pinnacle.
What generics did Elite have before NH came on board? Phentermine? And what else?
In order to generate money to support the R&D projects, required testing from independent sources, and help keep the business afloat by adding money to the company coffers, the generics NH brought to Elite via Mikah were essential to the survival of Elite.
Trimipramine does not add that much in the way of revenue, but it does showcase Elite's willingness and flexibility to bring much needed drugs to the market without the money attachments 95% of pharmaceuticals require. Elite's willingness to do this also helped resolve a shortage problem with this particular generic.
And since the point was brought up about greed, why is it Elite was not so much concerned about getting high profile generics to market rather than generics most companies gave up on because they don't generate
high cash flow? In my opinion this was a very smart move on NH's part
for two reasons. The fact that these generics were tossed out by other pharmas because they didn't generate enough cash to make it worth while for those particular larger pharmacueticals, BUT are generics that are still in demand(needed). And the second reason, easiest way to generate cash is with generics which are still in demand, but have fewer manufacturers due in part to other pharmas going for bigger cash flow targets.
Very smart business decision by Elite as a whole.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM